FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2606469665> ?p ?o ?g. }

• W2606469665 endingPage "24" @default.
• W2606469665 startingPage "15" @default.
• W2606469665 abstract "Circulating levels of microRNA (miR)-133a are increased in patients with coronary atherosclerotic disease (CAD). Whether the cardiac release of this miR provides any prognostic information in patients with CAD is currently unknown. We aimed to investigate if changes in concentration of miR-133a trough the coronary circulation may be associated with patients' cardiovascular outcome. We enrolled 111 patients (82 with stable CAD and 29 with acute coronary syndromes [ACS]) who underwent coronary angiography. Circulating levels of miR-133a were measured across the transcoronary circulation. Major adverse cardiac events (MACE: death, nonfatal myocardial infarction, and need for revascularization) were recorded through a median follow-up of 32 months. An increased transcoronary concentration gradient of miR133a showed a significant association with overall rate of MACE at follow-up in patients with both stable CAD and ACS (p = 0.011 and p = 0.002, respectively). At the single end point-analysis, increased transcoronary concentration gradients of miR133a were significantly associated with increased rate of death in patients with ACS (p = 0.017) and with increased incidence of new revascularization because of in-stent restenosis in patients with stable CAD (p = 0.026). Kaplan-Meier curves showed a significantly worse event-free survival in patients with greater transcoronary gradients of miR133a (p = 0.026 in stable CAD group and p = 0.007 for ACS group). Nevertheless, these findings lost their significance after adjustment for common cardiovascular risk factor and high-sensitivity troponin-T. In conclusions, the release of miR133a, as measured by its transcoronary concentration gradient, is associated with a higher incidence of MACE in patients with CAD, but it does not add significant prognostic information compared with traditional prognostic biomarkers, therefore limiting its potential usefulness in the clinical practice. Nevertheless, the differential modulation of miR-133a release in the coronary circulation may reflect pathophysiological mechanism involved in CAD progression and complications and suggest a novel potential role for this miR in the development of in-stent restenosis. Circulating levels of microRNA (miR)-133a are increased in patients with coronary atherosclerotic disease (CAD). Whether the cardiac release of this miR provides any prognostic information in patients with CAD is currently unknown. We aimed to investigate if changes in concentration of miR-133a trough the coronary circulation may be associated with patients' cardiovascular outcome. We enrolled 111 patients (82 with stable CAD and 29 with acute coronary syndromes [ACS]) who underwent coronary angiography. Circulating levels of miR-133a were measured across the transcoronary circulation. Major adverse cardiac events (MACE: death, nonfatal myocardial infarction, and need for revascularization) were recorded through a median follow-up of 32 months. An increased transcoronary concentration gradient of miR133a showed a significant association with overall rate of MACE at follow-up in patients with both stable CAD and ACS (p = 0.011 and p = 0.002, respectively). At the single end point-analysis, increased transcoronary concentration gradients of miR133a were significantly associated with increased rate of death in patients with ACS (p = 0.017) and with increased incidence of new revascularization because of in-stent restenosis in patients with stable CAD (p = 0.026). Kaplan-Meier curves showed a significantly worse event-free survival in patients with greater transcoronary gradients of miR133a (p = 0.026 in stable CAD group and p = 0.007 for ACS group). Nevertheless, these findings lost their significance after adjustment for common cardiovascular risk factor and high-sensitivity troponin-T. In conclusions, the release of miR133a, as measured by its transcoronary concentration gradient, is associated with a higher incidence of MACE in patients with CAD, but it does not add significant prognostic information compared with traditional prognostic biomarkers, therefore limiting its potential usefulness in the clinical practice. Nevertheless, the differential modulation of miR-133a release in the coronary circulation may reflect pathophysiological mechanism involved in CAD progression and complications and suggest a novel potential role for this miR in the development of in-stent restenosis." @default.
• W2606469665 created "2017-04-28" @default.
• W2606469665 creator A5005924135 @default.
• W2606469665 creator A5006076673 @default.
• W2606469665 creator A5025706940 @default.
• W2606469665 creator A5039638412 @default.
• W2606469665 creator A5061907666 @default.
• W2606469665 creator A5064540641 @default.
• W2606469665 creator A5077770411 @default.
• W2606469665 creator A5080632467 @default.
• W2606469665 date "2017-07-01" @default.
• W2606469665 modified "2023-10-02" @default.
• W2606469665 title "Transcoronary Concentration Gradient of microRNA-133a and Outcome in Patients With Coronary Artery Disease" @default.
• W2606469665 cites W1936833235 @default.
• W2606469665 cites W1971726501 @default.
• W2606469665 cites W1977111128 @default.
• W2606469665 cites W1980888291 @default.
• W2606469665 cites W1988964743 @default.
• W2606469665 cites W2029199297 @default.
• W2606469665 cites W2043469561 @default.
• W2606469665 cites W2057599529 @default.
• W2606469665 cites W2097233439 @default.
• W2606469665 cites W2105397247 @default.
• W2606469665 cites W2109341154 @default.
• W2606469665 cites W2121822802 @default.
• W2606469665 cites W2130772763 @default.
• W2606469665 cites W2136625479 @default.
• W2606469665 cites W2149256184 @default.
• W2606469665 cites W2149365884 @default.
• W2606469665 cites W2157184686 @default.
• W2606469665 cites W2157454492 @default.
• W2606469665 cites W2166950143 @default.
• W2606469665 cites W2171232191 @default.
• W2606469665 cites W2171241454 @default.
• W2606469665 cites W2246715603 @default.
• W2606469665 cites W4236531408 @default.
• W2606469665 cites W4293577771 @default.
• W2606469665 doi "https://doi.org/10.1016/j.amjcard.2017.03.264" @default.
• W2606469665 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28511772" @default.
• W2606469665 hasPublicationYear "2017" @default.
• W2606469665 type Work @default.
• W2606469665 sameAs 2606469665 @default.
• W2606469665 citedByCount "45" @default.
• W2606469665 countsByYear W26064696652017 @default.
• W2606469665 countsByYear W26064696652018 @default.
• W2606469665 countsByYear W26064696652019 @default.
• W2606469665 countsByYear W26064696652020 @default.
• W2606469665 countsByYear W26064696652021 @default.
• W2606469665 countsByYear W26064696652022 @default.
• W2606469665 countsByYear W26064696652023 @default.
• W2606469665 crossrefType "journal-article" @default.
• W2606469665 hasAuthorship W2606469665A5005924135 @default.
• W2606469665 hasAuthorship W2606469665A5006076673 @default.
• W2606469665 hasAuthorship W2606469665A5025706940 @default.
• W2606469665 hasAuthorship W2606469665A5039638412 @default.
• W2606469665 hasAuthorship W2606469665A5061907666 @default.
• W2606469665 hasAuthorship W2606469665A5064540641 @default.
• W2606469665 hasAuthorship W2606469665A5077770411 @default.
• W2606469665 hasAuthorship W2606469665A5080632467 @default.
• W2606469665 hasConcept C126322002 @default.
• W2606469665 hasConcept C164705383 @default.
• W2606469665 hasConcept C2778213512 @default.
• W2606469665 hasConcept C2779464278 @default.
• W2606469665 hasConcept C2780400711 @default.
• W2606469665 hasConcept C2780739214 @default.
• W2606469665 hasConcept C500558357 @default.
• W2606469665 hasConcept C71924100 @default.
• W2606469665 hasConceptScore W2606469665C126322002 @default.
• W2606469665 hasConceptScore W2606469665C164705383 @default.
• W2606469665 hasConceptScore W2606469665C2778213512 @default.
• W2606469665 hasConceptScore W2606469665C2779464278 @default.
• W2606469665 hasConceptScore W2606469665C2780400711 @default.
• W2606469665 hasConceptScore W2606469665C2780739214 @default.
• W2606469665 hasConceptScore W2606469665C500558357 @default.
• W2606469665 hasConceptScore W2606469665C71924100 @default.
• W2606469665 hasIssue "1" @default.
• W2606469665 hasLocation W26064696651 @default.
• W2606469665 hasLocation W26064696652 @default.
• W2606469665 hasOpenAccess W2606469665 @default.
• W2606469665 hasPrimaryLocation W26064696651 @default.
• W2606469665 hasRelatedWork W1871392962 @default.
• W2606469665 hasRelatedWork W1987806665 @default.
• W2606469665 hasRelatedWork W2049397185 @default.
• W2606469665 hasRelatedWork W2089715561 @default.
• W2606469665 hasRelatedWork W2110653948 @default.
• W2606469665 hasRelatedWork W2399063111 @default.
• W2606469665 hasRelatedWork W2943471851 @default.
• W2606469665 hasRelatedWork W2969704120 @default.
• W2606469665 hasRelatedWork W3206201424 @default.
• W2606469665 hasRelatedWork W4304166097 @default.
• W2606469665 hasVolume "120" @default.
• W2606469665 isParatext "false" @default.
• W2606469665 isRetracted "false" @default.
• W2606469665 magId "2606469665" @default.
• W2606469665 workType "article" @default.